| Gerson Davi Braga Smith, LPN | |
|
3320 Auburn Way N, Auburn, WA 98002-1805 | |
| (253) 999-5750 | |
| Not Available |
| Full Name | Gerson Davi Braga Smith |
|---|---|
| Gender | Male |
| Speciality | Licensed Practical Nurse |
| Location | 3320 Auburn Way N, Auburn, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205693496 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | LP61333010 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gerson Davi Braga Smith, LPN 3320 Auburn Way N, Auburn, WA 98002-1805 Ph: (253) 999-5750 | Gerson Davi Braga Smith, LPN 3320 Auburn Way N, Auburn, WA 98002-1805 Ph: (253) 999-5750 |
News Archive
Queensland University of Technology researchers have identified a drug that could potentially help our brains reboot and reverse the damaging impacts of heavy alcohol consumption on regeneration of brain cells.
The percentage of young adults ages 18 to 34 in Texas without health insurance has dropped by 35 percent since the Affordable Care Act went into effect, according to a new report released today by Rice University's Baker Institute for Public Policy and the Episcopal Health Foundation.
The Wall Street Journal reports that draft regulations "being developed by the Obama administration say more than half of employer health care plans may lose their grandfathered status and be required to comply with the health overhaul bill approved March 23. The guidelines are likely to touch off fresh disputes between President Obama and opponents of the health care bill.
A new review article in the June issue of Focal Points, a monthly publication of the American Academy of Ophthalmology, calls keratoprosthesis a viable alternative to standard corneal transplantation to help people suffering from corneal blindness.
Bristol-Myers Squibb Company today announced results from the Phase IIb EMERGE clinical trial, in which treatment with the investigational compound PEG-Interferon lambda and ribavirin achieved higher rates of rapid virologic response in genotypes 1, 2, 3, and 4, and complete early virologic response in genotypes 1 and 4 than the standard regimen of PEG-Interferon alfa and ribavirin in treatment-naïve patients chronically infected with hepatitis C.
› Verified 6 days ago
Lory Malana, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 505 29th St Se, Sound Mental Health, Auburn, WA 98002 Phone: 253-876-7650 Fax: 253-876-7651 | |
Beverly Cruz Menjivar, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3320 Auburn Way N, Auburn, WA 98002 Phone: 253-999-5750 Fax: 253-999-5740 | |
Laura Landon, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 30313 118th Ave Se, Auburn, WA 98092 Phone: 360-825-6525 | |
Monde Imbula Coffee, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 505 29th St Se, Auburn, WA 98002 Phone: 253-876-7650 | |
Catherine Wairimu Muriithi, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1426 Ginkgo St Se, Auburn, WA 98092 Phone: 253-248-9098 | |
Jasmine Nicole Hammar, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 402 21st St Se Apt 14, Auburn, WA 98002 Phone: 661-341-7750 | |
Rhonda L Veary, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 502 4th St Ne, Auburn, WA 98002 Phone: 253-931-4927 |